Research graph
References from Evolutionary and structural pathways of antibody maturation reveal principles for engineering potent SARS-CoV-2 neutralizers. Local targets link to admitted publications; unresolved targets remain external evidence.
10.1016/j.softx.2015.06.001 · 2015 · Admitted local publication
Computational approach for binding prediction of SARS-CoV-2 with neutralizing antibodies
10.1016/j.csbj.2022.04.038 · 2022 · External reference
Implementation of the CHARMM force field in GROMACS: analysis of protein stability effects from correction maps, virtual interaction sites, and water models
10.1021/ct900549r · 2010 · External reference
Rational optimization of a human neutralizing antibody of SARS-CoV-2
10.1016/j.compbiomed.2021.104550 · 2021 · External reference
Controlled human infection models to accelerate vaccine development
2026 · External reference
WebLogo: a sequence logo generator
10.1101/gr.849004 · 2004 · External reference
MolProbity: all-atom contacts and structure validation for proteins and nucleic acids
10.1093/nar/gkm216 · 2007 · External reference
Structure-based antigen design: a strategy for next generation vaccines
10.1016/j.tibtech.2008.08.002 · 2008 · External reference
Integrity of immunoglobulin variable regions is supported by GANP during AID-induced somatic hypermutation in germinal center B cells
10.1093/intimm/dxx032 · 2017 · External reference
Computational methods in immunology and vaccinology: design and development of antibodies and immunogens
10.1021/acs.jctc.3c00513 · 2023 · External reference
Hierarchical clustering can identify B cell clones with high confidence in Ig repertoire sequencing data
10.4049/jimmunol.1601850 · 2017 · External reference
In silico identification and analysis of potentially bioactive antiviral phytochemicals against SARS-CoV-2: a molecular docking and dynamics simulation approach
10.1155/2023/5469258 · 2023 · External reference
Improved HIV-1 neutralization breadth and potency of V2-apex antibodies by in silico design
10.1016/j.celrep.2023.112711 · 2023 · External reference
The ClusPro web server for protein-protein docking
10.1038/nprot.2016.169 · 2017 · External reference
An insight of in silico and in vitro evaluation of catechins and L-theanine from Camellia sinensis (L.) against Alzheimer’s disease targeting cholinesterases and β-secretase
10.1016/j.insi.2025.100020 · 2025 · External reference
Induction of IGHV3-53 public antibodies with broadly neutralising activity against SARS-CoV-2 including omicron subvariants in a Delta breakthrough infection case
10.1016/j.ebiom.2024.105439 · 2024 · External reference
Introductory tutorials for simulating protein dynamics with GROMACS
10.1021/acs.jpcb.4c04901 · 2024 · External reference
Navigating the post-COVID-19 immunological era: understanding long COVID-19 and immune response
10.3390/life13112121 · 2023 · External reference
Structural delineation and computational design of SARS-CoV-2-neutralizing antibodies against omicron subvariants
10.1038/s41467-023-39890-8 · 2023 · External reference
Affinity maturation of SARS-CoV-2 neutralizing antibodies confers potency, breadth, and resilience to viral escape mutations
10.1016/j.immuni.2021.07.008 · 2021 · External reference
Insights into SARS-CoV-2 genome, structure, evolution, pathogenesis and therapies: structural genomics approach
10.1016/j.bbadis.2020.165878 · 2020 · External reference
Antibodies to combat viral infections: development strategies and progress
10.1038/s41573-022-00495-3 · 2022 · External reference
Clustal omega for making accurate alignments of many protein sequences
10.1002/pro.3290 · 2018 · External reference
Visualizing antibody affinity maturation in germinal centers
10.1126/science.aad3439 · 2016 · External reference
Discovery of a novel public antibody lineage correlated with inactivated SARS-CoV-2 vaccine and the resultant neutralization activity
10.1002/jmv.70073 · 2024 · External reference
Discovery of a novel public antibody lineage correlated with inactivated SARS-CoV-2 vaccine and the resultant neutralization activity
10.1002/jmv.70073 · 2024 · External reference
Novel monoclonal antibodies and recombined antibodies against variant SARS-CoV-2
10.3389/fimmu.2021.715464 · 2021 · External reference
The HDOCK server for integrated protein–protein docking
10.1038/s41596-020-0312-x · 2020 · External reference
IgBLAST: an immunoglobulin variable domain sequence analysis tool
10.1093/nar/gkt382 · 2013 · External reference
Affinity maturation for antibody engineering: the critical role of residues on CDR loops of antibodies in antigen binding
10.3390/molecules30030532 · 2025 · External reference
Somatically hypermutated antibodies isolated from SARS-CoV-2 Delta infected patients cross-neutralize heterologous variants
2023 · External reference
Somatic hypermutation generates antibody specificities beyond the primary repertoire
10.1016/j.immuni.2025.04.014 · 2025 · External reference
